Breaking News Instant updates and real-time market news.

IBM

IBM

$121.84

-1.99 (-1.61%)

16:13
01/22/19
01/22
16:13
01/22/19
16:13

IBM reports Q4 cognitive solutions revenue flat from last year at $5.5B

Reports Q4 Global Business Services revenues of $4.3B, up 4%, Technology Services & Cloud Platforms revenues of $8.9B, down 3%, and Systems revenues of $2.6B, down 21%.

  • 22

    Jan

  • 25

    Feb

  • 03

    Mar

  • 04

    Mar

IBM IBM
$121.84

-1.99 (-1.61%)

12/20/18
SBSH
12/20/18
DOWNGRADE
Target $26
SBSH
Neutral
Citi downgrades Sanmina to Neutral, cuts IBM target to $125
Citi analyst Jim Suva downgraded Sanmina (SANM) to Neutral from Buy and lowered his price target for the shares to $26 from $35. The analyst also cut his price target for Neutral-rated IBM (IBM) to $125 from $165. The outlook for 2019 shows slowing growth across most end markets, Suva tells investors in a research note. As such, he expects tech companies to increase their M&A actions coupled with production or sourcing moves away from China.
01/15/19
STFL
01/15/19
NO CHANGE
Target $145
STFL
Buy
IBM price target lowered to $145 from $178 at Stifel
Stifel analyst David Grossman said he expects IBM's EPS and free cash flow to remain relatively flat in 2019 and 2020 on both a reported and pro forma basis before he sees growth resuming in 2021. He also noted that currency headwinds have increased significantly over the past three months, which is likely to impact reported revenue versus consensus. Grossman, who thinks the stock should set up favorably in a defensive market, keeps a Buy rating on IBM but lowered his price target for shares to $145 from $178.
01/15/19
NOMU
01/15/19
NO CHANGE
Target $160
NOMU
Buy
Nomura Instinet calls IBM 'preferred tech defensive play' for 2019
Nomura Instinet analyst Jeffrey Kvaal lowered his price target for IBM to $160 from $170 but keeps a Buy rating on the shares. The analyst reduced his estimates and price target to reflect unfavorable currency shifts. However, he expects IBM's Q4 to offer "stronger growth" in Strategic Imperatives, a Transaction Processing recovery, and a return to billings growth. IBM is Kvaal's preferred tech defensive play given its "high annuity revenue, a likely return to sales growth, and a low valuation."
01/15/19
UBSW
01/15/19
NO CHANGE
Target $150
UBSW
Buy
IBM weakness a buying opportunity, says UBS
UBS analyst John Roy said the selloff in IBM appears to be overdone. The analyst believes the stock is reflecting some of the challenges the company is facing, but he expects the multiple to expand once its pending deals are closed. He believes 2019 could be a transitional year as its Red Hat deal closes, its software portfolio returns to organic growth, and its momentum in GBS remains strong. Roy reiterated his Buy rating and $150 price target on IBM shares.

TODAY'S FREE FLY STORIES

XYF

X Financial

$6.23

0.715 (12.98%)

17:23
03/18/19
03/18
17:23
03/18/19
17:23
Earnings
X Financial reports Q4 EPS 24c, two estimates 24c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

CADE

Cadence Bancorp

$20.24

0.51 (2.58%)

17:22
03/18/19
03/18
17:22
03/18/19
17:22
Hot Stocks
Cadence Bancorp President Samuel Tortorici buys almost $1M in company shares »

Cadence Bancorp President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

CELP

Cypress Energy

$7.41

0.06 (0.82%)

17:22
03/18/19
03/18
17:22
03/18/19
17:22
Syndicate
Breaking Syndicate news story on Cypress Energy »

Cypress Energy files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

JWN

Nordstrom

$44.21

0.465 (1.06%)

17:21
03/18/19
03/18
17:21
03/18/19
17:21
Syndicate
Breaking Syndicate news story on Nordstrom »

Nordstrom files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$171.73

2.13 (1.26%)

17:20
03/18/19
03/18
17:20
03/18/19
17:20
Hot Stocks
General Dynamics awarded $2.04B Navy submarine material contract modification »

General Dynamics has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

FFIN

First Financial

$61.60

0.44 (0.72%)

, MBFI

MB Financial

$47.20

0.63 (1.35%)

17:19
03/18/19
03/18
17:19
03/18/19
17:19
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

First Financial…

FFIN

First Financial

$61.60

0.44 (0.72%)

MBFI

MB Financial

$47.20

0.63 (1.35%)

FOE

Ferro

$18.88

0.125 (0.67%)

FITB

Fifth Third

$28.74

0.42 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 16

    Apr

  • 23

    Apr

  • 23

    Apr

FOE

Ferro

$18.88

0.125 (0.67%)

, FFIN

First Financial

$61.60

0.44 (0.72%)

17:17
03/18/19
03/18
17:17
03/18/19
17:17
Hot Stocks
Breaking Hot Stocks news story on Ferro, First Financial »

Ferro to replace First…

FOE

Ferro

$18.88

0.125 (0.67%)

FFIN

First Financial

$61.60

0.44 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

FFIN

First Financial

$61.60

0.44 (0.72%)

, MBFI

MB Financial

$47.20

0.63 (1.35%)

17:17
03/18/19
03/18
17:17
03/18/19
17:17
Hot Stocks
First Financial to replace MB Financial in S&P 400 at open on 3/22 »

Fifth Third Bancorp…

FFIN

First Financial

$61.60

0.44 (0.72%)

MBFI

MB Financial

$47.20

0.63 (1.35%)

FITB

Fifth Third

$28.74

0.42 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 16

    Apr

  • 23

    Apr

  • 23

    Apr

CUTR

Cutera

$18.00

-0.29 (-1.59%)

17:13
03/18/19
03/18
17:13
03/18/19
17:13
Hot Stocks
Cutera director Daniel Plants buys almost $1.5M in company shares »

Cutera director Daniel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

SMTX

SMTC Corp.

$4.41

-0.1 (-2.22%)

17:13
03/18/19
03/18
17:13
03/18/19
17:13
Syndicate
Breaking Syndicate news story on SMTC Corp. »

SMTC Corp. files $50M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 28

    May

SNE

Sony

$46.10

-0.16 (-0.35%)

, AAPL

Apple

$188.03

1.83 (0.98%)

17:09
03/18/19
03/18
17:09
03/18/19
17:09
Periodicals
PlayStation Vue now lets Apple TV users watch four channels at once, Verge says »

According to the…

SNE

Sony

$46.10

-0.16 (-0.35%)

AAPL

Apple

$188.03

1.83 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRRM

Verra Mobility

$10.89

0.15 (1.40%)

17:08
03/18/19
03/18
17:08
03/18/19
17:08
Earnings
Verra Mobility reports Q4 net ($38.0M) vs. ($29.2M) last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

EQH

AXA Equitable

$20.86

0.09 (0.43%)

17:06
03/18/19
03/18
17:06
03/18/19
17:06
Syndicate
AXA Equitable files to sell 40M shares of common stock for holders »

In connection with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$113.07

-1.89 (-1.64%)

17:04
03/18/19
03/18
17:04
03/18/19
17:04
Hot Stocks
ESPN+ to become exclusive distributor of UFC Pay-Per-View events »

UFC and ESPN+ announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

STML

Stemline

$12.92

-0.71 (-5.21%)

17:02
03/18/19
03/18
17:02
03/18/19
17:02
Recommendations
Stemline analyst commentary at Piper Jaffray »

Stemline sees positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REV

Revlon

$19.39

0.42 (2.21%)

17:02
03/18/19
03/18
17:02
03/18/19
17:02
Hot Stocks
Revlon down 15% after Q4 results miss estimates »

The company also…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ATR

AptarGroup

$103.69

0.75 (0.73%)

17:01
03/18/19
03/18
17:01
03/18/19
17:01
Hot Stocks
AptarGroup's Bidose approved by FDA for breakthrough treatment of depression »

Aptar Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

  • 01

    May

XELA

Exela Technologies

$3.82

-0.03 (-0.78%)

16:57
03/18/19
03/18
16:57
03/18/19
16:57
Earnings
Exela Technologies sees FY19 revenue $1.66B-$1.7B, consensus $1.68B »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

XELA

Exela Technologies

$3.82

-0.03 (-0.78%)

16:56
03/18/19
03/18
16:56
03/18/19
16:56
Earnings
Exela Technologies reports Q4 revenue $399.6M, consensus $401.4M »

Reports Q4 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

BIO

Bio-Rad

$313.64

3.58 (1.15%)

16:55
03/18/19
03/18
16:55
03/18/19
16:55
Hot Stocks
Bio-Rad extends 10-K filing by 15 days to complete year-end procedures »

In a regulatory 8-K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$47.09

0.09 (0.19%)

16:55
03/18/19
03/18
16:55
03/18/19
16:55
Conference/Events
Aerie Pharmaceuticals management to meet with JMP Securities »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 08

    Apr

NOMD

Nomad Foods

$21.45

-0.07 (-0.33%)

16:54
03/18/19
03/18
16:54
03/18/19
16:54
Syndicate
Nomad Foods files to sell 20M ordinary shares »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIS

FIS

$108.14

-0.73 (-0.67%)

, WP

Worldpay

$108.52

9.8 (9.93%)

16:54
03/18/19
03/18
16:54
03/18/19
16:54
Conference/Events
FIS management to meet with Wolfe Research »

Senior Payments & IT…

FIS

FIS

$108.14

-0.73 (-0.67%)

WP

Worldpay

$108.52

9.8 (9.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 18

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 04

    Apr

ORN

Orion Group

$4.23

0.145 (3.55%)

16:52
03/18/19
03/18
16:52
03/18/19
16:52
Hot Stocks
Orion Group delays filing of Form 10-K »

Orion Group Holdings said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

YEXT

Yext

$23.00

0.33 (1.46%)

16:50
03/18/19
03/18
16:50
03/18/19
16:50
Syndicate
Yext files to sell 6.1M shares of common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.